Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Orikine Announces Sabrina Kuttruff Coqui As Chief Executive Officer and Joachim Koch As Chief Scientific Officer and Chief Development Officer

PRIVATESep 08, 2026•about 2 hours ago

Position

Chief Scientific Officer

Company

Orikine Bio

Joachim Koch
BarcelonaBiotechnologyHealth Care

Description

Orikine Bio has appointed Sabrina Kuttruff-Coqui as Chief Executive Officer and Joachim Koch as Chief Scientific Officer and Chief Development Officer to support its next stage of corporate development. The expanded leadership team aims to advance ORK1 towards the clinic and enhance Orikine's growth strategy. Additionally, Andreas Muehler joins as part-time Chief Medical Officer.

Company Information

Company

Orikine Bio

Location

Barcelona, Catalonia, Spain

About

Orikine is a biotechnology company pioneering bi-specific cytokines to reprogram the immune system and treat autoimmune and chronic inflammatory diseases. The company is transitioning from a research-driven organization to one focused on delivering clinical potential from its pipeline. With an experienced leadership team, Orikine is well-positioned for growth through future financing and partnership opportunities.

Don't miss Orikine Bio's next move

Get an email the moment Orikine Bio changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Orikine Bio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Orikine Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.